Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04995081 · ClinicalTrials.gov registry record · Phase 2

Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD)

A Phase 2 study of Parkinson Disease, sponsored by Hope Biosciences Research Foundation.

Completed
Registry status
Phase 2
Development phase
60
Enrollment target
1
Study location

NCT04995081 is a Phase 2 study of Parkinson Disease that has completed, run by Hope Biosciences Research Foundation. The registered enrollment target is 60 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04995081, a Phase 2 study of Parkinson Disease, has completed, sponsored by Hope Biosciences Research Foundation.

COMPLETED
Registry status
Phase 2
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This is a randomized, double-blind, single center, phase 2 study to assess efficacy and safety of multiple allogeneic HB-adMSCs vs Placebo for the treatment of Parkinson's disease.

Conditions Studied

Parkinson Disease

Interventions

  • OTHER Placebo
  • BIOLOGICAL Biological/Vaccine: Allogeneic HB-adMSCs

Study Locations (1)

Texas

  • Hope Biosciences Stem Cell Research Foundation - Sugar Land

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2021-07-16
Est. Completion 2025-10-03
Phase Phase 2

Sponsor

Hope Biosciences Research Foundation

9 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04995081

The ClinicalTrials.gov registry entry for NCT04995081 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The listed sponsor is Hope Biosciences Research Foundation, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT04995081 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT04995081 about?

NCT04995081 is a clinical study titled "Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD)". This is a randomized, double-blind, single center, phase 2 study to assess efficacy and safety of multiple allogeneic HB-adMSCs vs Placebo for the treatment of Parkinson's disease.

What is the current status of trial NCT04995081?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2021-07-16. Estimated completion is 2025-10-03.

What conditions does trial NCT04995081 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT04995081?

The interventions under investigation include: Placebo (OTHER), Biological/Vaccine: Allogeneic HB-adMSCs (BIOLOGICAL).

Who is sponsoring clinical trial NCT04995081?

This trial is sponsored by Hope Biosciences Research Foundation, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04995081 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson Disease

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.